Skip links

Should the TRIPS Waiver be expanded to Covid-19 therapeutics and diagnostics?



Zoom, Virtual Meeting

Wednesday 5th October 2022
0900 Washington DC : 1500 Geneva

WTO members will decide over the next months whether to expand the TRIPS waiver from vaccines to Covid therapeutics and diagnostics. This panel will discuss the implications for innovation, manufacturing and access.


Jennifer Brant
Executive Director, Innovation Council, Switzerland

Mark Schultz, Professor of Intellectual Property Law, University of Akron and co-author of the Global Trade Secrets Protection Index

Mark Schultz
Professor of Intellectual Property Law, University of Akron, USA and co-founder of the Center for Intellectual Property x Innovation Policy (C-IP2)

Amir Ullah Khan
Research Director at the Centre for Development Policy and Practice in Hyderabad, India

Prof. Bryan Mercurio
Simon F.S. Li Professor of Law at the Chinese University of Hong Kong


Philip Stevens
Executive Director, Geneva Network